What the study measured
Investigators gave 845 participants oral glucose-tolerance tests four hours and one hour before their usual bedtime. The sequence was randomized; each person experienced both conditions after fasting. [1]
Natural melatonin was higher in the later condition. Glucose exposure was higher and insulin exposure lower, with a stronger glucose-tolerance effect in carriers of a particular MTNR1B risk allele. [1]
How far the finding goes
The intervention changed glucose-test timing; it did not randomly assign melatonin tablets. The result therefore cannot supply a supplement dose, prove that a tablet causes diabetes or isolate every influence of time of day. Funding and conflicts were not established from the abstract. [1]
A glucose challenge is also not a measurement of years of diabetes outcomes. The appropriate conclusion keeps the timing, laboratory endpoint and genetic subgroup attached to the result, rather than converting an acute response into a personal disease prediction. [1]
A hypothetical distinction
Imagine the same test produces different responses at two times of day. That identifies a timing-dependent response, but it does not show what would happen after adding a pill that was never tested.
| Detail | Interpretation |
|---|---|
| 845 people | Within-person timing comparison |
| Endogenous melatonin | Naturally occurring hormone |
| Supplement treatment | Not randomized here |
Sources for this article
- Interplay of Dinner Timing and MTNR1B Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.